MediFind Announced as Finalist for Reuter’s Pharma Awards USA: Most Valuable Service or Digital Therapy

The Reuters Events’ Pharma Awards USA focus on what really matters: value for patients and customers. Recognizing innovative and meaningful approaches: this is the work worth applauding. The awards focus on initiatives that deliver outcomes, restore pharma’s reputation and celebrate real achievements.

Specifically, the Most Valuable Service or Digital Therapy category focuses on initiatives that go beyond the pill, providing a holistic service or solution that provides significant benefit to patients.

The formal awards ceremony is scheduled for December 7-9, 2020. Read more about the award and the other finalists here.

About Phreesia Life Sciences

Phreesia is the trusted leader in patient activation, giving providers, health plans, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled more than 120 million patient visits in 2022—more than 1 in 10 visits across the U.S.—scale that we believe allows us to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes. To learn more, visit

Press contact:

Carly Helfand